Company Overview
Snapshot
Founded in January 2007, VVT Medical operates with 11–50 employees. The company has raised $2.6 million across two funding rounds. VVT Medical became publicly listed on the TSX Venture Exchange in July 2025.
Business overview
VVT Medical specializes in the research, development, manufacturing, and commercialization of minimally invasive, non-thermal non-tumescent (NT-NT) solutions for treating varicose veins. Its core product, the ScleroSafe platform, combined with V-Block technology, offers a patented delivery system for performing quick, office-based procedures without the need for tumescent anesthesia or costly capital equipment. The company's solutions are designed for various outpatient settings, including vein clinics, day care clinics, angio suites, catheterization laboratories, and hospitals, targeting the healthcare and life sciences sectors.
Strategic signal
VVT Medical is actively expanding its global commercial footprint and strengthening its capital structure. In August 2026, the company announced a debt settlement and equity incentive grants. This follows significant European expansion, including an exclusive distribution agreement in Greece in June 2026 and its largest European distribution agreement to date in April 2026, signaling robust market penetration and strategic financial management to support its growth trajectory.
Log in to access full profile ›Company Intelligence Q&A
- What was a significant recent financial development for VVT Medical?
- In August 2026, VVT Medical announced a debt settlement and equity incentive grants aimed at strengthening its capital structure.
- When did VVT Medical expand its European commercial footprint?
- In June 2026, VVT Medical expanded its European commercial footprint through an exclusive distribution agreement in Greece.
- What was a key market expansion for VVT Medical in June 2026?
- In June 2026, VVT Medical expanded into the Dominican Republic by appointing Antilles Medical as its exclusive distributor.
- What was the outcome of VVT Medical's largest European distribution agreement?
- In April 2026, VVT Medical signed its largest European distribution agreement to date, with the distributor also joining as an investor.
- When did VVT Medical become publicly traded?
- VVT Medical commenced trading on the TSX Venture Exchange in July 2025.